BRPI0511371A - esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparação - Google Patents
esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparaçãoInfo
- Publication number
- BRPI0511371A BRPI0511371A BRPI0511371-7A BRPI0511371A BRPI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A BR PI0511371 A BRPI0511371 A BR PI0511371A
- Authority
- BR
- Brazil
- Prior art keywords
- liposomes
- amphotericin
- saline
- mixed
- lamellated
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 3
- 229930183010 Amphotericin Natural products 0.000 title abstract 2
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title abstract 2
- 229930182558 Sterol Natural products 0.000 title abstract 2
- 229940009444 amphotericin Drugs 0.000 title abstract 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title abstract 2
- 239000011780 sodium chloride Substances 0.000 title abstract 2
- 150000003432 sterols Chemical class 0.000 title abstract 2
- 235000003702 sterols Nutrition 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000009830 intercalation Methods 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 244000000040 protozoan parasite Species 0.000 abstract 1
- 238000000527 sonication Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1113DE2004 | 2004-06-11 | ||
| PCT/IN2005/000193 WO2005120460A1 (en) | 2004-06-11 | 2005-06-13 | Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511371A true BRPI0511371A (pt) | 2008-03-11 |
Family
ID=34972096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511371-7A BRPI0511371A (pt) | 2004-06-11 | 2005-06-13 | esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparação |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070218119A1 (enExample) |
| EP (1) | EP1771156B8 (enExample) |
| JP (1) | JP4966855B2 (enExample) |
| CN (1) | CN101014322A (enExample) |
| AT (1) | ATE476965T1 (enExample) |
| AU (1) | AU2005251572B2 (enExample) |
| BR (1) | BRPI0511371A (enExample) |
| DE (1) | DE602005022876D1 (enExample) |
| WO (1) | WO2005120460A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2481100C2 (ru) * | 2009-10-16 | 2013-05-10 | Лайфкеа Инновейшнз Пвт. Лтд. | Новая лекарственная форма для лечения грибковой инфекции |
| WO2017150705A1 (ja) * | 2016-03-04 | 2017-09-08 | 栗田工業株式会社 | 選択性透過膜及びその製造方法、該選択性透過膜を用いる水処理方法 |
| JP7355335B2 (ja) * | 2017-10-11 | 2023-10-03 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ | 小分子重炭酸イオンチャネルを用いた嚢胞性線維症の遺伝子型非依存性救済 |
| KR20240164801A (ko) | 2022-03-21 | 2024-11-20 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 암포테리신 b의 지질-코팅된 결정을 포함하는 이온 채널 보형 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2134869A (en) * | 1983-02-15 | 1984-08-22 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
| US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
| US4766046A (en) * | 1985-09-27 | 1988-08-23 | Liposome Technology, Inc. | Stabilized liposome/amphotericin composition and method |
-
2005
- 2005-06-13 AT AT05759293T patent/ATE476965T1/de not_active IP Right Cessation
- 2005-06-13 BR BRPI0511371-7A patent/BRPI0511371A/pt active Search and Examination
- 2005-06-13 CN CNA200580023366XA patent/CN101014322A/zh active Pending
- 2005-06-13 JP JP2007526704A patent/JP4966855B2/ja not_active Expired - Fee Related
- 2005-06-13 WO PCT/IN2005/000193 patent/WO2005120460A1/en not_active Ceased
- 2005-06-13 US US11/570,379 patent/US20070218119A1/en not_active Abandoned
- 2005-06-13 DE DE602005022876T patent/DE602005022876D1/de not_active Expired - Lifetime
- 2005-06-13 AU AU2005251572A patent/AU2005251572B2/en not_active Ceased
- 2005-06-13 EP EP05759293A patent/EP1771156B8/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN101014322A (zh) | 2007-08-08 |
| EP1771156B1 (en) | 2010-08-11 |
| EP1771156B8 (en) | 2010-09-15 |
| US20070218119A1 (en) | 2007-09-20 |
| JP2008501782A (ja) | 2008-01-24 |
| ATE476965T1 (de) | 2010-08-15 |
| AU2005251572A1 (en) | 2005-12-22 |
| DE602005022876D1 (de) | 2010-09-23 |
| WO2005120460A1 (en) | 2005-12-22 |
| AU2005251572B2 (en) | 2010-03-11 |
| EP1771156A1 (en) | 2007-04-11 |
| JP4966855B2 (ja) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27186A1 (es) | Formulación farmacéutica | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| CY1111359T1 (el) | Μεμαντινη για την θεραπεια ηπιας εως μετριας ασθενειας alzheimer | |
| BRPI0415858A (pt) | compostos de medicamentos terapêuticos modificados por tocoferol | |
| PT1299130E (pt) | Processo papa o tratamento e prevencao de doencas infecciosas | |
| BR0008135A (pt) | Composto, métodos para tratar uma infecção por vìrus em um ser humano e para tratar uma infecção pelo vìrus da hepatite b em um ser humano, composição farmacêutica, uso de um composto, método para liberar um composto, pacote para paciente, processo para a preparação de um composto | |
| BRPI0418157A (pt) | terapêutica de tumores alogênicos | |
| BRPI0513622A (pt) | aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes | |
| EA201001287A1 (ru) | Лечение гиперглицемии 25-гидроксивитамином d3 | |
| BRPI0511371A (pt) | esterol enriquecido e misturado com anfotericina lamelada, intercalada com liposomos em solução salina e o processo para a sua preparação | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| BRPI0414518A (pt) | composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| BR0108283A (pt) | Uso de fosfato de estramustina ou um seu metabólito na preparação de um medicamento, agente para uso na potenciação da eficácia terapêutica de um taxano, combinação que potencia a eficácia terapêutica de um taxano, processo e método de potenciar a eficácia terapêutica de um taxano | |
| EA200501252A1 (ru) | Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты) | |
| Ahmed et al. | Effect of wet cupping therapy on virulent cellulitis secondary to honey bee sting-a case report | |
| MXPA05005021A (es) | Pure de papaya y uso del mismo. | |
| Turlaev et al. | Socio-economic aspects of the development of hirudotherapy in Russia | |
| Kupferschmidt | 'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter. | |
| BRPI0602179A (pt) | composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação | |
| BRPI0417797A (pt) | soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos | |
| BR0107058A (pt) | Processo para a preparação de uma vacina para o tratamento da tuberculose e de outras doenças e infecções intracelulares e a vacina produzida através desse processo | |
| Schatzberg et al. | Mirtazapine versus paroxetine in elderly depressed patients | |
| MD3381G2 (ro) | Metodă de tratament al parotiditei cronice la copii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |